Lung Institute | Buffalo New York

Pulmonary Fibrosis Treatment Near Buffalo, NY

Pulmonary fibrosis is a disease in which the lungs become scarred, causing airways inside the lungs to thicken and harden. This hardening makes it difficult for oxygen to pass through the walls of the tiny air sacs (alveoli) into the bloodstream. The lack of oxygen in the bloodstream leaves sufferers of pulmonary fibrosis short of breath even after periods of prolonged rest. Pulmonary fibrosis is a progressive disease in which sufferers get worse over time, sometimes slowly, other times rapidly.

Previously treatment options for those suffering from pulmonary fibrosis have been extremely limited and costly, ranging from daily medication to a lung reduction or transplant. Today, however, relatively new technology gives lung disease sufferers an alternative option. Minimally invasive bone marrow treatments for lung disease have helped several patients regain a better quality of life. The Lung Institute specializes in stem cell therapy treatments for those suffering from lung disease.

Patients can now take advantage of Pulmonary Fibrosis Treatment Near Buffalo, NY. The Lung Institute’s recently opened clinic in Pittsburgh, PA, offers alternatives to people suffering from lung disease.

About Stem Cell Therapy

Over the course of three days, a patient’s stem cells will be harvested from his or her bone marrow, processed and reintroduced into their body. After reintroduction, the stem cells can begin to slow down the progression of the disease. Everyone has stem cells in their own body that act the body’s healing system. Extracting and reintroducing stem cells to certain damaged areas of the body accelerates this process.

The Lung Institute uses autologous stem cells, derived from the patient’s own body for the bone marrow and the venous (blood-derived) stem cell procedures. Stem cells are extracted, isolated and immediately introduced back into the body where they replicate into healthy cells specialized to promote healing. All our stem cell procedures have shown anti-inflammatory properties beneficial to patients with lung disease.

The city of Pittsburgh leads lung disease research with programs like those at the Simmons Center for Interstitial Lung Disease at the University of Pittsburgh. The Pittsburgh Lung Institute clinic treats interstitial lung disease and other serious lung disorders including COPD, emphysema, chronic bronchitis, pulmonary fibrosis and black lung.

Lung disease is the third leading cause of death in the United States, and most traditional treatment options only treat the symptoms rather than the disease itself. Most who have been diagnosed with lung disease are prescribed a bronchodilator and daily medication to clear the respiratory path and reduce coughing. The advent of stem cell therapy is a game-changer for those with lung disease.

To date the Lung Institute has treated over 1,000 patients with stem cell therapy, and is excited to increase the number of improved lives with the addition of the Pittsburgh Clinic. Dr. Jack Coleman, Jr, MD, is the Medical Director for the Lung Institute in Pittsburgh. He earned his medical degree from the University of Cincinnati as well as completed his internship and general surgery residency at the institution. Dr. Coleman is a board certified in physician and ensures that all treatments and staff will follow strict standards with the highest excellence in personalized patient care.

About the Lung Institute

At the Lung Institute, we help those with lung disease breathe easier through innovative medical solutions. We understand the challenges that lung disease sufferers face when it comes to finding the best treatment option in order to obtain a better quality of life. With this in mind, we are committed to providing our patients with the best and most effective treatment options to bring their lives back within reach. For more information, visit our website at LungInstitute.com, like us on Facebook, Follow us on Twitter or call us today at (800) 729-3065.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.